Sosei Heptares teams up with Genentech for multi-target R&D

Drug Discovery |  News | 0 Comment | 17 Jul, 2019

Japan headquartered Sosei Group Corporation has entered into a multi-target research collaboration and license agreement with Genentech, a member of the Roche Group, to discover and develop...Read more

Eisai collaborates with University of Dundee for cancer drug discovery

Drug Discovery |  News | 0 Comment | 09 Jul, 2019

Japanese pharmaceutical firm Eisai Co.,Ltd. has announced that it has entered into a collaboration research agreement with the University of Dundee in Scotland, UK, regarding Proteolysis Ta...Read more

New Vaccine in the Treatment of Rheumatoid Arthritis

Drug Discovery |  News | 0 Comment | 09 Jul, 2019

CEL-SCI Corporation (NYSE American: CVM) announced that one of its key collaborators from Rush University Medical center, Dr. Adrienn Markovitz an Assistant professor in the depar...Read more

Singapore HSA approves Vosevi to treat Chronic Hepatitis C Virus

Drug Discovery |  News | 0 Comment | 25 Jun, 2019

Gilead Sciences, Inc., on 24 June 2019, announced that the Singapore Health Sciences Authority (HAS) has approved Vosevi (Sofosbuvir 400mg/Velpatasvir 100mg/Voxilaprevir 100mg), a once...Read more

Gilead collaborates with Nurix to develop new cancer therapies

Drug Discovery |  News | 0 Comment | 21 Jun, 2019

Gilead Sciences and Nurix Therapeutics, Inc., have announced a global strategic collaboration to discover, develop and commercialize a pipeline of innovative targeted protein degr...Read more

Zydus’ Nesher Pharma gets final USFDA nod for Lovaza capsules

Drug Discovery |  News | 0 Comment | 17 Jun, 2019

Zydus’ Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received the final approval from the USFDA to market Omega-3-Acid Ethyl Esters Capsules USP (US RLD &ndash...Read more

Acucela gets EMA approval for Emixustat to treat Stargardt disease

Drug Discovery |  News | 0 Comment | 11 Jun, 2019

Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), recently announced that th...Read more

Sosei Heptares to receive new $3 million milestone payment from Pfizer

Drug Discovery |  News | 0 Comment | 10 Jun, 2019

Sosei Group Corporation and its strategic alliance partner Pfizer announce that a new clinical candidate from their multi-target drug discovery collaboration was nominated to advance into c...Read more

CStone and Bayer to evaluate PD-L1 monoclonal antibody CS1001 in combination with regorafenib

Drug Discovery |  News | 0 Comment | 10 Jun, 2019

CStone Pharmaceuticals, on 9 June 2019, announced its global clinical collaboration with China focus with Bayer HealthCare LLC to evaluate the safety, tolerability, pharmacokineti...Read more

Luye Pharma's Rykindo gets NDA filing acceptance by USFDA

Drug Discovery |  News | 0 Comment | 30 May, 2019

Rykindo® (LY03004), Luye Pharma's innovative, independently developed Extended-Release Microspheres formulation for injection, is one step closer to going on the U.S...Read more

Sihuan Pharm achieves new grant approval

Drug Discovery |  News | 0 Comment | 28 May, 2019

Sihuan Pharmaceutical Holdings Group Ltd., the largest cardio-cerebral vascular (CCV) drug manufacturer in China's prescription drug market, announced its grant approval for "non-...Read more

BGU introduces Novel Combination Therapy for treating neurological disorders

Drug Discovery |  News | 0 Comment | 13 May, 2019

BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), introduces a novel drug combination therapy, based on two FDA approved drugs, for protecting the ...Read more

Taiwan Health Ministry approves Vemlidy for chronic hepatitis B

Drug Discovery |  News | 0 Comment | 30 Apr, 2019

Gilead Sciences, Inc. has recently announced that with effect from 1 May 2019, Vemlidy (tenofovir alafenamide, TAF) 25 mg, a once-daily treatment for chronic hepatitis B in adults with...Read more

ADC Therapeutics and Adagene announce discovery collaboration agreement

Drug Discovery |  News | 0 Comment | 25 Apr, 2019

ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of proprietary antibody drug conjugates (ADCs), and Adagene Inc., an antibody engine...Read more

Roche launches Emicizumab in India

Drug Discovery |  News | 0 Comment | 21 Apr, 2019

Roche has declared  that Emicizumab (Hemlibra®) has been approved in India for Hemophilia A with factor VIII inhibitors. It is indicated as a prophylactic(preventive) treatment to ...Read more

Japan grants Sakigake designation to Eisai’s novel FGFR

Drug Discovery |  News | 0 Comment | 08 Apr, 2019

Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. The company has announced that its in-house discovered fibroblast growth fa...Read more

Takeda takes step towards EU Entyvio extension

Drug Discovery |  News | 0 Comment | 02 Apr, 2019

Takeda Pharmaceutical Company Limited announced that the European Medicines Agency (EMA) has accepted a Marketing Authorization Line Extension Application for a subcutaneous (SC) formulatio...Read more

Standigm raises $11.5M in Series B Round

Drug Discovery |  News | 0 Comment | 02 Apr, 2019

Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced it has raised $11.5 million in a Series B funding round led by Mirae Asset Ve...Read more